86 related articles for article (PubMed ID: 2609523)
1. [The selective toxicity of 5-hydroxymethyldeoxyuridine for the cells of human adenocarcinoma of the large intestine].
Lockshin A; Meshcherikova VV
Vopr Onkol; 1989; 35(11):1327-32. PubMed ID: 2609523
[TBL] [Abstract][Full Text] [Related]
2. Selective cytotoxicity of 5-hydroxyuridine for human colon adenocarcinoma cells.
Lockshin A; Giovanella BC; Mendoza JT; Warneke C; Stehlin JS
Cancer Treat Rep; 1985; 69(7-8):845-50. PubMed ID: 3160461
[TBL] [Abstract][Full Text] [Related]
3. Cytotoxic activity of fusaric acid on human adenocarcinoma cells in tissue culture.
Fernandez-Pol JA; Klos DJ; Hamilton PD
Anticancer Res; 1993; 13(1):57-64. PubMed ID: 8476229
[TBL] [Abstract][Full Text] [Related]
4. In vivo antitumor activity of choline kinase inhibitors: a novel target for anticancer drug discovery.
Hernández-Alcoceba R; Fernández F; Lacal JC
Cancer Res; 1999 Jul; 59(13):3112-8. PubMed ID: 10397253
[TBL] [Abstract][Full Text] [Related]
5. (R,R)-2,2'-[1,2-ethanediylbis[imino(1-methyl-2,1-ethanediyl)]]- bis[5-nitro-1H-benz[de]isoquinoline-1,3-(2H)-dione] dimethanesulfonate (DMP 840), a novel bis-naphthalimide with potent nonselective tumoricidal activity in vitro.
Kirshenbaum MR; Chen SF; Behrens CH; Papp LM; Stafford MM; Sun JH; Behrens DL; Fredericks JR; Polkus ST; Sipple P
Cancer Res; 1994 Apr; 54(8):2199-206. PubMed ID: 8174127
[TBL] [Abstract][Full Text] [Related]
6. Influence of 1 and 25 Hz, 1.5 mT magnetic fields on antitumor drug potency in a human adenocarcinoma cell line.
Ruiz-Gómez MJ; de la Peña L; Prieto-Barcia MI; Pastor JM; Gil L; Martínez-Morillo M
Bioelectromagnetics; 2002 Dec; 23(8):578-85. PubMed ID: 12395412
[TBL] [Abstract][Full Text] [Related]
7. Biological properties of 4-methyl-2,7-diamino-5,10-diphenyl-4,9-diazapyrenium hydrogensulfate (ADAP).
Marczi S; Glavas-Obrovac L; Belovari T; Stojković R; Ivanković S; Serić V; Piantanida I; Zinić M
Cancer Chemother Pharmacol; 2008 Sep; 62(4):595-604. PubMed ID: 18034344
[TBL] [Abstract][Full Text] [Related]
8. Susceptibility of human colon carcinoma cells to anticancer drugs is enhanced by L-histidinol.
Warrington RC; Cheng I; Fang WD
Anticancer Res; 1994; 14(2A):367-72. PubMed ID: 8017835
[TBL] [Abstract][Full Text] [Related]
9. Antitumor activity of imidazothioxanthones in murine and human tumor models in vitro and in vivo.
Varvaresou A; Iakovou K; Gikas E; Fichtner I; Fiebig HH; Kelland LR; Double JA; Bibby MC; Hendriks HR
Anticancer Res; 2004; 24(2B):907-19. PubMed ID: 15161044
[TBL] [Abstract][Full Text] [Related]
10. Paclitaxel and radiotherapy: sequence-dependent efficacy--a preclinical model.
Niero A; Emiliani E; Monti G; Pironi F; Turci L; Valenti AM; Marangolo M
Clin Cancer Res; 1999 Aug; 5(8):2213-22. PubMed ID: 10473108
[TBL] [Abstract][Full Text] [Related]
11. The cytotoxicity of 3'-aminocyanoborane-2', 3'-dideoxypyrimidines in murine and human tissue cultured cell lines.
Burnham BS; Chen SY; Sood A; Spielvogel BF; Miller MC; Hall IH
Anticancer Res; 1995; 15(3):951-8. PubMed ID: 7645985
[TBL] [Abstract][Full Text] [Related]
12. Preclinical antitumor efficacy of the polyamine analogue N1, N11-diethylnorspermine administered by multiple injection or continuous infusion.
Bernacki RJ; Oberman EJ; Seweryniak KE; Atwood A; Bergeron RJ; Porter CW
Clin Cancer Res; 1995 Aug; 1(8):847-57. PubMed ID: 9816054
[TBL] [Abstract][Full Text] [Related]
13. Hybrid aza-steroid alkylators in the treatment of colon cancer.
Trafalis DT
Cancer Lett; 2006 Nov; 243(2):202-10. PubMed ID: 16412564
[TBL] [Abstract][Full Text] [Related]
14. A new screening system for NAD(P)H:quinone oxidoreductase (NQO1)-directed antitumor quinones: identification of a new aziridinylbenzoquinone, RH1, as a NQO1-directed antitumor agent.
Winski SL; Hargreaves RH; Butler J; Ross D
Clin Cancer Res; 1998 Dec; 4(12):3083-8. PubMed ID: 9865924
[TBL] [Abstract][Full Text] [Related]
15. AA1, a newly synthesized monovalent lipophilic cation, expresses potent in vivo antitumor activity.
Sun X; Wong JR; Song K; Hu J; Garlid KD; Chen LB
Cancer Res; 1994 Mar; 54(6):1465-71. PubMed ID: 8137249
[TBL] [Abstract][Full Text] [Related]
16. Paclitaxel and N-methylformamide: in vitro interactions in human colon cancer cell line.
Valenti AM; Niero A; Monti G; Marangolo F; Marangolo M
Anticancer Res; 1997; 17(4A):2491-7. PubMed ID: 9252669
[TBL] [Abstract][Full Text] [Related]
17. Highly selective drug combinations for human colon cancer cells resistant in vitro to 5-fluoro-2'-deoxyuridine.
Sobrero AF; Handschumacher RE; Bertino JR
Cancer Res; 1985 Jul; 45(7):3161-3. PubMed ID: 3159475
[TBL] [Abstract][Full Text] [Related]
18. Creatine and phosphocreatine analogs: anticancer activity and enzymatic analysis.
Bergnes G; Yuan W; Khandekar VS; O'Keefe MM; Martin KJ; Teicher BA; Kaddurah-Daouk R
Oncol Res; 1996; 8(3):121-30. PubMed ID: 8823808
[TBL] [Abstract][Full Text] [Related]
19. A search for multidrug resistance modulators: the effects of retinoids in human colon carcinoma cells.
Bartolini G; Orlandi M; Papi A; Ammar K; Guerra F; Ferreri AM; Rocchi P
In Vivo; 2006; 20(6A):729-33. PubMed ID: 17203756
[TBL] [Abstract][Full Text] [Related]
20. Flavone acetic acid: a novel agent with preclinical antitumor activity against colon adenocarcinoma 38 in mice.
Plowman J; Narayanan VL; Dykes D; Szarvasi E; Briet P; Yoder OC; Paull KD
Cancer Treat Rep; 1986 May; 70(5):631-5. PubMed ID: 3708611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]